Evidence map›Paper›PMID 35163216›Full record

ReviewInternational journal of molecular sciences2022

Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.

Shinya Yamada, Hidesaku Asakura

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. How We Interpret Thrombosis with Thrombocytopenia Syndrome?International journal of molecular sciences · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Therapeutic Targeting of the Proteolytic Enzymes.International journal of molecular sciences · 2022
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Shinya YamadaDepartment of Hematology, Kanazawa University Hospital, Kanazawa 920-8641, Japan.ORCID 0000-0002-7415-2918
Hidesaku AsakuraDepartment of Hematology, Kanazawa University Hospital, Kanazawa 920-8641, Japan.
Kanazawa University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aortic aneurysms are sometimes associated with enhanced-fibrinolytic-type disseminated intravascular coagulation (DIC). In enhanced-fibrinolytic-type DIC, both coagulation and fibrinolysis are markedly activated. Typical cases show decreased platelet counts and fibrinogen levels, increased concentrations of fibrin/fibrinogen degradation products (FDP) and D-dimer, and increased FDP/D-dimer ratios. Thrombin-antithrombin complex or prothrombin fragment 1 + 2, as markers of coagulation activation, and plasmin-α

Indexed as

alpha-2-AntiplasminAnticoagulantsAntifibrinolytic AgentsAortic AneurysmDisseminated Intravascular CoagulationFibrin Fibrinogen Degradation ProductsFibrinolysinFibrinolysisHeparinHumansPartial Thromboplastin TimeProthrombin Timealpha-2-AntiplasminAnticoagulantsAntifibrinolytic AgentsFibrin Fibrinogen Degradation Productsfibrin fragment DFibrinolysinHeparinplasmin-plasmin inhibitor complexdirect oral anticoagulantenhanced-fibrinolytic-type disseminated intravascular coagulationnafamostatserine proteasesynthetic protease inhibitor

Identifiers

PMID35163216
PMCPMC8836167
OpenAlexW4210482081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.